2.自己抗体の標的抗原―ITPを中心に

特発性血小板減少性紫斑病(ITP)は,血小板が自己抗体により早期に網内系にて破壊される自己免疫疾患である.全身性エリテマトーデス(SLE)が全身性疾患であるのに対し,バセドー病やITPは臓器特異的な自己免疫疾患である.ITPの病態さらにはその成因を解析するためには,ITPにおける自己抗体の標的抗原(=自己抗原)を明らかにする必要がある.本稿では,ITPにおける標的抗原の詳細を中心に,その病態解析に関する最近の進歩につき概説する....

Full description

Saved in:
Bibliographic Details
Published in日本内科学会雑誌 Vol. 103; no. 7; pp. 1570 - 1579
Main Author 冨山, 佳昭
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本内科学会 2014
Subjects
Online AccessGet full text
ISSN0021-5384
1883-2083
DOI10.2169/naika.103.1570

Cover

Abstract 特発性血小板減少性紫斑病(ITP)は,血小板が自己抗体により早期に網内系にて破壊される自己免疫疾患である.全身性エリテマトーデス(SLE)が全身性疾患であるのに対し,バセドー病やITPは臓器特異的な自己免疫疾患である.ITPの病態さらにはその成因を解析するためには,ITPにおける自己抗体の標的抗原(=自己抗原)を明らかにする必要がある.本稿では,ITPにおける標的抗原の詳細を中心に,その病態解析に関する最近の進歩につき概説する.
AbstractList 特発性血小板減少性紫斑病(ITP)は,血小板が自己抗体により早期に網内系にて破壊される自己免疫疾患である.全身性エリテマトーデス(SLE)が全身性疾患であるのに対し,バセドー病やITPは臓器特異的な自己免疫疾患である.ITPの病態さらにはその成因を解析するためには,ITPにおける自己抗体の標的抗原(=自己抗原)を明らかにする必要がある.本稿では,ITPにおける標的抗原の詳細を中心に,その病態解析に関する最近の進歩につき概説する.
Author 冨山, 佳昭
Author_xml – sequence: 1
  fullname: 冨山, 佳昭
  organization: 大阪大学附属病院輸血部
BookMark eNo9j79Lw0AcxQ-pYKxd_S8Sv3eX3F1GLf4oFHSo83GXSzSxRkm6uFkVBIcOiogurqIoOOmg-L-Yprr5LxiruLzH48HjfaZRLd1JQ4RmMTgEM38uVfGWcjBQB3scJpCFhaA2AUFryAIg2PaocKdQI89jDS5lnsDUtRAmXy-Dz-Pb8ulxdHIxfD0r-g-jm8uPq6MqloPr9_3zVmetODgdPt-Xb4dF_24GTUaqm4eNP6-j9aXFTnPFbq8ut5rzbTshhIHtUxNg7glOOQHm60iDMJoA90kAimlmXO1FhouAYc2Y1pp4EVEhwaY6anxaRwu_u0neUxuh3M3ibZXtSZX14qAbyjGxrIglH-sP938ZbKpMJop-A1OXYoE
ContentType Journal Article
Copyright 2014 一般社団法人 日本内科学会
Copyright_xml – notice: 2014 一般社団法人 日本内科学会
DOI 10.2169/naika.103.1570
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1883-2083
EndPage 1579
ExternalDocumentID article_naika_103_7_103_1570_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
DIK
F5P
JSF
OK1
RJT
ID FETCH-LOGICAL-j2260-93dc17587372069bfb08db20792c0a6b6d4b5fd78c61b66bbb25f2ae21d384d93
ISSN 0021-5384
IngestDate Wed Sep 03 06:30:13 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 7
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2260-93dc17587372069bfb08db20792c0a6b6d4b5fd78c61b66bbb25f2ae21d384d93
OpenAccessLink https://www.jstage.jst.go.jp/article/naika/103/7/103_1570/_article/-char/ja
PageCount 10
ParticipantIDs jstage_primary_article_naika_103_7_103_1570_article_char_ja
PublicationCentury 2000
PublicationDate 20140000
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – year: 2014
  text: 20140000
PublicationDecade 2010
PublicationTitle 日本内科学会雑誌
PublicationTitleAlternate 日内会誌
PublicationYear 2014
Publisher 一般社団法人 日本内科学会
Publisher_xml – name: 一般社団法人 日本内科学会
References 11) Tomiyama Y, Kosugi S: Autoantigenic epitopes on platelet glycoproteins. Int J Hematol 81: 100-105, 2005.
2) Cines DB, Blanchette VS: Immune thrombocytopenic purpura. N Engl J Med 346: 995-1008, 2002.
7) 冨山佳昭: トロンボポエチン受容体作動薬による難治性ITPの治療. 臨血 52: 627-632, 2011.
19) Yu J, et al: Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood 112: 1325-1328, 2008.
13) Tomiyama Y, et al: Demonstration of platelet antigens that bind platelet-associated autoantibodies in chronic ITP by direct immunoprecipitation procedure. Br J Haematol 75: 92-98, 1990.
1) Harrington WJ, et al: Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 38: 1-10, 1951.
5) Rodeghiero F, et al: Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113: 2386-2393, 2009.
20) Stasi R, et al: Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood 112: 1147-1150, 2008.
18) Semple JW, Provan D: The immunopathogenesis of immune thrombocytopenia: T cells still take center-stage. Curr Opin Hematol 19: 357-362, 2012.
3) McMillan R: The pathogenesis of chronic immune thrombocytopenic purpura. Semin Hematol 44 (Suppl 5): S3-S11, 2007.
9) McMillan R, et al: Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 70: 1040-1045, 1987.
15) Fujisawa K, et al: The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura. Blood 81: 2872-2877, 1993.
8) Kelton JG, et al: A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpura. Blood 60: 1050-1053, 1982.
17) Kuwana M, et al: Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura: role in production of anti-platelet autoantibody. J Clin Invest 102: 1393-1402, 1998.
10) Kiefel V, et al: Autoantibodies against platelet glycoprotein Ib/IX: a frequent finding in autoimmune thrombocytopenic purpura. Br J Haematol 79: 256-262, 1991.
6) McMillan R, et al: Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 103: 1364-1369, 2004.
16) Kiyomizu K, et al: Recognition of highly restricted regions in the β-propeller domain of αIIb by platelet-associated anti-αIIbβ3 autoantibodies in primary immune thrombocytopenia. Blood 120: 1499-1509, 2012.
14) Brighton TA, et al: Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood 88: 194-201, 1996.
12) McMillan R, et al: Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP). J Thromb Haemost 1: 485-491, 2003.
4) 冨山佳昭: 特発性血小板減少性紫斑病. 臨血 49: 1298-1305, 2008.
References_xml – reference: 11) Tomiyama Y, Kosugi S: Autoantigenic epitopes on platelet glycoproteins. Int J Hematol 81: 100-105, 2005.
– reference: 1) Harrington WJ, et al: Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 38: 1-10, 1951.
– reference: 20) Stasi R, et al: Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood 112: 1147-1150, 2008.
– reference: 13) Tomiyama Y, et al: Demonstration of platelet antigens that bind platelet-associated autoantibodies in chronic ITP by direct immunoprecipitation procedure. Br J Haematol 75: 92-98, 1990.
– reference: 19) Yu J, et al: Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood 112: 1325-1328, 2008.
– reference: 9) McMillan R, et al: Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 70: 1040-1045, 1987.
– reference: 7) 冨山佳昭: トロンボポエチン受容体作動薬による難治性ITPの治療. 臨血 52: 627-632, 2011.
– reference: 12) McMillan R, et al: Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP). J Thromb Haemost 1: 485-491, 2003.
– reference: 18) Semple JW, Provan D: The immunopathogenesis of immune thrombocytopenia: T cells still take center-stage. Curr Opin Hematol 19: 357-362, 2012.
– reference: 16) Kiyomizu K, et al: Recognition of highly restricted regions in the β-propeller domain of αIIb by platelet-associated anti-αIIbβ3 autoantibodies in primary immune thrombocytopenia. Blood 120: 1499-1509, 2012.
– reference: 4) 冨山佳昭: 特発性血小板減少性紫斑病. 臨血 49: 1298-1305, 2008.
– reference: 5) Rodeghiero F, et al: Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113: 2386-2393, 2009.
– reference: 17) Kuwana M, et al: Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura: role in production of anti-platelet autoantibody. J Clin Invest 102: 1393-1402, 1998.
– reference: 10) Kiefel V, et al: Autoantibodies against platelet glycoprotein Ib/IX: a frequent finding in autoimmune thrombocytopenic purpura. Br J Haematol 79: 256-262, 1991.
– reference: 6) McMillan R, et al: Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 103: 1364-1369, 2004.
– reference: 8) Kelton JG, et al: A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpura. Blood 60: 1050-1053, 1982.
– reference: 2) Cines DB, Blanchette VS: Immune thrombocytopenic purpura. N Engl J Med 346: 995-1008, 2002.
– reference: 15) Fujisawa K, et al: The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura. Blood 81: 2872-2877, 1993.
– reference: 14) Brighton TA, et al: Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood 88: 194-201, 1996.
– reference: 3) McMillan R: The pathogenesis of chronic immune thrombocytopenic purpura. Semin Hematol 44 (Suppl 5): S3-S11, 2007.
SSID ssib043658134
ssj0066765
ssib002821954
ssib005879745
ssib007485360
ssib058493862
ssib000940260
ssib002484664
Score 1.9584438
Snippet ...
SourceID jstage
SourceType Publisher
StartPage 1570
SubjectTerms GPIIb-IIIa
PAIgG
T細胞異常
自己抗原
Title 2.自己抗体の標的抗原―ITPを中心に
URI https://www.jstage.jst.go.jp/article/naika/103/7/103_1570/_article/-char/ja
Volume 103
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本内科学会雑誌, 2014/07/10, Vol.103(7), pp.1570-1579
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Ni9QwFC_rCuJF_MRv9uC7KF2btGkTPKWzHVZlRWEW9laafhzmMIrMXjy5Kgge9qCI6MWrKAqe9KD4vzi7qzf_Bd9LOzMd2IO7Qgltmvzee3lJ-xKS9xznkqfKjNyeuzmZb0EpfFeJjLkmqFhVMqm4pAPOK7fC5dXgxppYmztwubVraX1oFvMHu54r2Y9WMQ_1Sqdk96DZCShm4D3qF1PUMKb_pGMOSRfiDsgEEgk4rdcaEgFxBDGDJASpQUWQBBAvgfIh8dFuBJ3QKy1BKUgiUBpk0CosCE11x5sgxPXebVuRg-IWSoJeslS6ICeYcdvIJTSE0sLedEB3LCySEERRI1FGOYijQ4vZITYSBSq2ryQJIifrt01tZJnIMrqwYzRyxb6lQly1VzDYdO2y4RqloUaSlh3kAjMTAkSa2mIgkhK2sMbryv6kaP8FOHPxQ18zUtYffil97Ft1UJ3Jn8HzW0Mgan3nmajDnTQ2Az6q3f5HnIXkznVAp8HIvcHitN6Mj--mB6W2YIoF08imVDwdv6RjeGkf5wIHeRQx2r56807LlFYBuYdrmV5yJnIATq1Z2_WfkJFqRzqIAjTcpvUDH01TNnUdiHaq8mU4cc1GW6Pr6CBNW9YOUUngq7PiomnXx4nOeJOktdt6R50jzYRrQdfiHXPm-tlx59BKs6XkhMP4n2-bv5--3_7yeefZq63vL0Ybn3bevf715gk-bm--_fnwJQ6B0aPnW18_bv94PNr4cNJZ7Sa9zrLbxBFx-zi58FzlFzlaydJGZAqVqYwnC8O9SPHcy0ITFoERVRHJPGQmDI0xXFQ8KzkrULBC-aec-cHdQXnaWajKIGMcK2BbB6XMM5OJkuWBQlivKOUZ51otbHqvdhaT7kW1Z_-r9jnnMI2uen3wvDM_vL9eXkCLeWgu2q7yF_dnlYI
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2%EF%BC%8E%E8%87%AA%E5%B7%B1%E6%8A%97%E4%BD%93%E3%81%AE%E6%A8%99%E7%9A%84%E6%8A%97%E5%8E%9F%E2%80%95ITP%E3%82%92%E4%B8%AD%E5%BF%83%E3%81%AB&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E5%86%A8%E5%B1%B1%2C+%E4%BD%B3%E6%98%AD&rft.date=2014&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5384&rft.eissn=1883-2083&rft.volume=103&rft.issue=7&rft.spage=1570&rft.epage=1579&rft_id=info:doi/10.2169%2Fnaika.103.1570&rft.externalDocID=article_naika_103_7_103_1570_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5384&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5384&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5384&client=summon